HEROIN: AN OPIATE DRUG OF ABUSE
Joanna Rocco
Heroin is a drug that is produced from morphine, which is
isolated from opium. Opium, in turn, comes from the opium poppy.
Opium use has a long and rich history. Use of opium may date back
as far as 6,000 years. It is likely that opium was used by
ancient Egyptians, Greeks, and Romans. Opium was imported to
China around 800 A.D. and eventually use of opium became
widespread there and all through Europe.
For many years opium, or morphine, was used medically to
treat a variety of ailments. It was primarily used as a cough
suppressant and a pain reliever. Opium was first brought to the
medical community in 1680 by a physician named Thomas Syndenham.
In 1803 morphine was isolated from opium by Frederick Serturner.
In 1874 heroin (diacetylmorphine) was first produced from
morphine. In 1898 the Bayer Company packaged and marketed heroin
as a substitute for morphine. In 1914 the Harrison narcotic act
added a tax on opiate distribution, and in 1924 the Heroin Act was
passed, which made manufacture and possession of heroin illegal.
The use and abuse of opioids is still on the rise. It is estimated
that as many as 8 million people around the world are currently
abusing these substances (Brink & Ree, 2003).
In the early 1970s researchers at New York University and
Johns Hopkins found that the brain had its own natural and
specific opiate receptor sites (Palfai & Jankiewicz, 2001). The
goal was to find out why. These receptors were found in high
concentrations in the limbic system and in pathways for chronic
pain. It was discovered that even a vertebrate as ancient as the
hagfish had opiate receptors. Eventually it was discovered that
the body manufactured its own opiates known as endorphins which
are made when the body experiences pain or stress.
The pain killing effect of endorphins occurs when they flood
the space between nerve cells and inhibit neurons from firing.
Endorphins, like opiates, can create feelings of euphoria and
relief from pain. Heroin is metabolized to morphine, and as it
reaches the brain the morphine molecule attaches to endorphin
receptors creating feelings of warmth, euphoria, relaxation,
drowsiness, and satisfaction (Young, 1999).
Addictive drugs activate processes of reward and mimic or
copy natural transmitters which then change brain circuits which
are involved in learning. What is, in part, so dangerous about
addictive drugs is this ability to affect brain chemistry in such
a profound way. What opiates do primarily is to inhibit GABA
neurons that usually in turn inhibit dopaminergic neurons in the
ventral tegmental area of the brain. This leads to a rush of
dopamine in the nucleus accumbens as well as other mesolimbic and
mesocortical brain regions (Kreek, Laforge, & Butelman, 2002).
Addictive drugs such as heroin are able to block or short-
circuit the brain's natural reward pathways. Normally these
pathways help us to survive, but the drug has such a strong effect
on memory and learning that getting the effect produced by the
drug becomes more important (Young, 1999). The mesolimbic
dopamine system is a very important part of the brain's reward
system. Nerve cells originating in the ventral tegmental area
near the base of the brain send messages to the nucleus accumbens
deep beneath the frontal cortex. The VTA neurons send out
dopamine from the terminal boutons to the receptors on nucleus
accumbens neurons. This dopamine pathway plays a crucial part in
the role of addiction (Nestler & Malenka, 2004). Animals with
lesions or tumors in these parts of the brain don't show interest
in addictive drugs, while healthy animals quickly learn to self
administer drugs such as heroin by pressing a lever.
Continued use of heroin will cause tolerance, dependence, and
eventually addiction and withdrawal. Tolerance occurs when more
and more heroin is needed to produce the euphoria and other
desirable effects of the drug. Addiction is the physical and
psychological need for heroin. The user begins to crave the drug
and will go to greater and greater lengths to obtain it.
Withdrawal occurs when the heroin user experiences negative or
adverse affects if he doesn't use heroin for a certain amount of
time. Once a user reaches this stage the habit often begins to
harm his health, finances and personal relationships (Nestler &
Malenka, 2004).
When heroin is used initially, endorphins and the
neurotransmitter dopamine (DA) play important roles in reinforcing
the effects of the drug. The primary brain areas associated with
this initial effect are the ventral tegmental area (VTA) and the
nucleus accumbens (NcA). When drug use is continued and cravings
for the drug begin to develop, many neurotransmitters become
involved. In addition to dopamine there is also corticotrophin
releasing hormone in the amygdale and glutamate in the frontal
cingulated circuit. In detoxification and withdrawal,
norepinephrine and glutamate are pronounced and the locus
coeruleus is the brain region most affected. In relapse, y amino
butyric acid or GABA and glutamate are involved in the
compulsivity of heroin addiction while norepinephribe (NE) seems
to play a role in the brain's stress system (Brink & Ree, 2003).
Addiction refers to compulsive use of a drug in spite of
harmful and unpleasant consequences. Heroin use changes chemistry
and brain function for a long time after the last use. In mice
studies it was found that certain stable proteins rise in the
brain during drug use and remain active for months. Long term
exposure to heroin may even cause the neurons of the nucleus
accumbens to sprout extra terminal spines, thereby supporting
these cell's connections to other neurons throughout the brain and
further reinforcing use of the drug (Nestler & Malenka, 2004).
Treatment of heroin addiction is tricky, and relapse rates are
high. Even with all this discouraging evidence however, there are
options for treatment of opiate addiction, unlike cocaine
addiction, which has few means of treatment. There are a variety
of ways to interrupt the addictive process, both pharmacologically
and socially.
Before treatment can begin, the user must go through what is
known as detoxification. Some people just stop taking the drug
abruptly, a method known as going "cold turkey." More often the
heroin is replaced by another opiate or an opiod-agonist such as
methadone, which is then tapered down. Often heroin addicts are
maintained for long periods on the drug methadone, a synthetic
analgesic and morphine like agonist. Other opiate agonists are
also used. These drugs block the effects of opiates and the
purpose of the treatment is to break the reward cycle of heroin
use (Palfai & Jankiewicz, 2001). There are studies being done on
the effects of drugs such as naltrexone and buprenorphine to see
if they may be more affective than methadone in long term
abstinence of heroin use (Lange, Fudala, Dax, & Johnson, 1990).
Lastly there is heroin maintenance or heroin assisted treatment.
This was introduced in Switzerland in 1994 and keeps addicts on a
low level of the drug. This treatment method is very
controversial. Heroin maintenance may reduce crime associated
with the use of the drug, but does little in terms of actually
getting the addict off of heroin altogether (Kilias & Rabasa,
1998).
Drug related cues or "triggers" play an important role in
relapse. Studies with rats show that those animals with a higher
degree of use before detoxification were more likely to seek out
heroin when cues were introduced, even after a significant amount
of time without the drug (Shaham, Highfield, Delfs, Leung, &
Stewart, 2000). This emphasizes the importance of avoiding
people, places and things an addict associates with past drug use
in the prevention of relapse.
Stress is another important factor in relapse. It has been
shown that norepinephrine (NE) neurons in the pons and medulla of
the brain contribute to relapse. In rats stress is induced by
using foot shock, and does increase a reinstatement of heroin use
after a time of abstinence (Zhang, Zhou, Tang, Lai, Liu, & Yang,
2003). It is therefore important for a recovering addict to
engage in some activity, be it counseling or involvement in a 12
step group that helps him deal with life stressors. The use of
adrenergic receptor agonists such as clonidine in heroin treatment
and relapse prevention is still being investigated (Shaham et al.,
2000).
Addiction to heroin is a condition that is chronic and
lifelong. The "how" of addiction is becoming more and more
understood, while the "why" of addiction is still not fully
understood. Why do some people seem to be so much more vulnerable
to addiction than others? It is a complex process that most
likely involves a genetic component and environmental factors
(Brink & Ree, 2003). It is also important to note that the reason
for the use of the drug may also play a factor. Young (1999)
suggests that voluntary use of a drug might activate different
chemical systems in the brain than when the drug is administered
by a doctor in a hospital, for example. Addiction involves
interaction between one's brain chemistry, particular genetic
vulnerability, and a person's own life experiences.
Studies continue to move forward toward the search for a
neurobilogical cause. It is theorized that permanent dysfunctions
of the dopaminergic system may be responsible. It is even
possible that someday a specific marker may be discovered that can
identify people at risk for addiction and perhaps predict the risk
of relapse (Czermak et al., 2004). Drug addiction costs the
United States almost $300 billion a year which makes it one of the
most serious problems facing society today (Nestler & Malenka,
2004).
References
Brink, W., & Ree, J.M. (2003). Pharmacological treatments for
heroin and cocaine addiction. European Neuropsychopharmacology,
13, 476-487.
Czermak, C., Lehofer, M., Wagner, E., Prietl, B., Lemonis, L.,
Rohrhofer, A., Schauenstein, K., & Liebmann, P.M. (2004). Reduced
dopamine D4 receptor mRNA expression in lymphocytes of long term
abstinent alcohol and heroin addicts. Addiction, 99, 251-257.
Kilias, M., & Rabasa, J. (1998). Does heroin prescription reduce
crime? Results from the evaluation of the Swiss Heroin
Prescription projects. Studies on Crime Prevention, 7, 127-133.
Kreek, M.J., LaForge, K.S., & Butelman, E. (2002). Pharmacotherapy
of addictions. National Review, 1, 710-726.
Lange, W.R., Fudala, P.J., Dax, E.M., & Johnson, R.E. (1990).
Safety and side effects of buprenorphine in the clinical
management of heroin addiction. Drug and Alcohol Dependence, 26,
19-28.
Nestler, E.J., & Malenka, R.C. (2004). The addicted brain.
Scientific American, 290(3).
Palfai, T., & Jankiewicz, H. (2001). Drugs and human behavior (2nd
ed.). New York: McGraw Hill.
Shaham, Y., Highfield, D., Delfs, J., & Sterwart, J. (2000).
Clonidine blocks stress induced reinstatement of heroin seeking in
rats: an effect independent of locus coeruleus noradrenergic
neurons. European Journal of Neuroscience, 12, 292-302.
Young, A.M. (1999). Addictive drugs and the brain. National Forum,
79, 15-23.
Zhang, F., Zhou, W., Tang, S., Lai, M., Liu, H., & Yang, G.
(2004). Motivation of heroin seeking elicited by drug associated
cues is related to total amount of heroin exposure during self
administration in rats. Pharmacology, Biochemistry and Behavior,
79, 291-298.
THE CHEMISTRY AND PHARMACOLOGY OF HEROIN
Heather French
Neurons, synaptic transmitters, and inhibitory and excitatory
potential changes: Heroin's affect on the brain
Heroin, or diacetylmorphine, is an opiate derivative and an opioid
agonist (Smith, 2003.) Opiate derivatives bind to pain receptors
in the surface membrane of cells in the brain known as opiate
receptors, therefore preventing pain or causing a sense of
euphoria for users who are not experiencing pain (Doweiko, 2002.)
Most opiates bind fairly selectively to one of three types of
receptors (mu, delta, and kappa) known as mu receptors (North,
1993.) Potassium channels on these neurons are opened by opioids,
which then results in hyperpolarization and a reduction in firing.
This then causes less GABA to be released onto the dopamine cells,
and consequently the dopamine cells fire more rapidly (North,
1993.) However, some researchers have found that heroin does not
bind to these known receptors.
Heroin seems to be more of a prodrug, or a compound that is
biotransformed by the liver into a compound that is biologically
active. This compound is technically a metabolite of the parent
drug and has a stronger biological action than the parent compound
(Doweiko, 2002.) This phenomenon occurs when heroin is deacylated
by pseudocholinestarase and nonspecific liver carboxylesterases
hCE1 and hCE2 to active metabolites 6monoacetylmorphine and
morphine (Smith, 2003). Essentially, heroin is active through its
biotransformation into morphine. Heroin molecules are hydrolyzed
into morphine molecules in the brain (Palfai & Jankiewicz, 2001.)
The chemistry of heroin
The chemical structures of heroin and morphine are quite similar
(see figure 1.) The heroin molecule is essentially a morphine
molecule with two acetyl groups added to it between the identical
alcohol and phenylhydroxyl groups (Palfai & Jankiewicz, 2001.)
The routes of access for heroin
There are several routes of access for heroin. When taken
intranasally, or snorted, about 25% of the available heroin in the
heroin powder is absorbed into the body through the nasal
membranes (Doweiko, 2002; Brick & Erickson, 1998.) When heroin is
smoked, it is well absorbed through the lungs. However, the
process of smoking destroys approximately 80% of the heroin, so
the user needs a very potent and plentiful supply in order to
achieve the same affects (Doweiko, 2002.) Heroin is most
affective when taken by injection. It can be injected
intravenously, intramuscularly, and subcutaneously. When
administered intravenously 100% of the drug is absorbed (Doweiko,
2002; Brick & Erickson, 1998.) The high success rate of using
heroin by this method of administration is illustrated in the
figure below (see figure 2.)
The pharmacology of heroin
The pharmacological characteristics of heroin produce a more
potent analgesic than morphine. "A standard conversion formula is
that 4 milligrams (mg) of heroin is as powerful as 10 mg of
morphine (Doweiko, p. 173.)" Additionally, because it is much
more lipid soluble than morphine, heroin is able to cross the
blood brain barrier 100 times faster than morphine (Doweiko,
2002.) The typical onset of heroin is approximately 15 minutes,
as compared to 20 minutes for morphine (Brick & Erickson, 1998.)
Peak effects of both heroin and morphine are commonly experienced
within 60 minutes, with the typical duration lasting between 4 to
5 hours for heroin and approximately 7 hours for morphine (Brick &
Erickson, 1998.) Heroin has a half life of only 3 minutes,
although one of its primary metabolites has an analgesic potential
and its half life is approximately 30 minutes (Doweiko, 2002.)
References
Brick, J., & Erickson, C. (1998). Drugs, the Brain, and Behavior.
Binghamton, NY: The Haworth Medical Press, Inc.
Doweiko, H. (Ed.) (2002). Concepts of chemical dependency (5th
ed). Pacific Grove, CA: BROOKS/COLE.
North, R. Cellular basis of opioid action. In Korenman, S., &
Barchas, J. (Eds). Biological Basis of Substance Abuse. (1993).
Oxford: Oxford University Press.
Palfai, T., & Jankiewicz, H. (2001). Drugs and Human Behavior (2nd
ed). New York: McGraw-Hill Primis Custom Publishing.
Smith, H. (2003). Drugs for Pain. Philadelphia, PA: Hanley &
Belfus, Inc.
Physiological and Primary Behavior Changes Related to Heroin Use
Erin C. Villa
PHYSIOLOGICAL CHANGES:
Heroin or diacetylmorphine also known on the street as horse,
smack, jive, junk, golden brown, black tar, etcetera, is one of a
group of drugs called 'opiates', which are derived from the opium
plant. Compounds like heroin, which come from alterations of the
morphine molecule, along with other synthetic painkillers
unrelated to morphine or heroin by structure or potency, are
called opioids (Palfai, & Jankiewicz, 2001). Heroin being a
derivative of morphine and morphine being opium's most potent
active ingredient, once introduced to the body whether through
inhalation, injection, or ingestion can have serious health
consequences. However, injected IM or IV, heroin is about three
times as potent (Palfai & Jankiewicz, 2001). Heroin, the most
fast-acting of all the opiates when injected, it reaches the brain
in around 15-30 seconds and within one minute the surge of
pleasure seems to start in the abdomen; a delicious warmth then
spreads throughout the body (HYPERLINK '
http://www.heroin.org/heroin.html '). Heroin and other opiates are
sedative drugs that depress the central nervous system by slowing
down body functioning and are able to combat both physical and
emotional pain (HYPERLINK ' http://www.drugscope.org.uk '). It
does this by mimicking the action of natural chemicals in our
body, endorphins and these endorphins are involved in respiration,
nausea, vomiting, pain modulation, hormonal regulations and
itching (HYPERLINK ' http://www.heroin.org/heroin.html ').
Although the CNS is affected with the introduction of heroin in
the body, there are also peripheral affects (HYPERLINK '
http://www.emedicine.com/med/topic1003.htm '). In the article
Toxicity, Heroin (2004), Dr. Laurie Grier explains these effects
as follows:
CNS:
Mild to moderate heroin toxicity manifests as analgesia,
drowsiness, reduced physical activity, and difficulty in
mentation.
Respiratory:
Respiratory depression is also a trademark of heroin and is the
result of CNS depression.
Heroin reduces the brain's responsiveness to changes in PCO2. With
high doses, heroin can also depress the brain's response to
hypoxia. This results in severe respiratory depression
progressing to apnea.
Tachypea may result from concomitant sympathomimetic intoxication,
hypoxia, and hypoglycemia.
Wheezing due to bronchospasm may be evident. Wheezing may also
indicate bronchospasm secondary to histamine release.
Eyes:
The presence of miosis in the setting of opioid toxicity,
including heroin. Miosis results when the mu and kappa receptors
of the parasympathetic nerve innervating the pupil are stimulated
by the heroin.
With mixed toxicities, mydriasis may also be noted.
Cardiovascular:
Mild bradycardia and mild hypotension.
Mild peripheral vasodilation occurs with reduced peripheral
resistance and inhibition of baroreceptor reflexes.
Blood pressure is usually well maintained unless the body is
stressed by hypoxia, hypovolemia, or acidosis.
Hypotension due to heroin is generally attributable to histamine
release and is observed in a number of opioid, including heroin.
Heroin my cause ventricular arrhythmias.
Gastrointestinal:
Decreased gastric motility, thereby prolonging gastric emptying
time by as much as 12 hours.
Heroin can also inhibit acetylcholine's effect on the small
intestine and diminish the colonic propulsive waves, thereby
delaying colonic emptying and resulting in constipation.
Skin:
Heroin causes vasodilatation of the cutaneous blood vessels,
resulting in flushing.
The vasodilatory effect may be enhanced by histamine release,
which also results in pruritus.
Stated succinctly, heroin/morphine reaches all body tissues. The
liver rapidly metabolizes opiates, biotransforming a significant
amount on the first pass, although this tends to vary widely among
people (Palfai & Jankiewicz, 2001). Due to this rapid
metabolizing, the high only ranges between 3-5 hours, depending on
the individual. This is a matter of great importance to the drug
dependent, who must seek another "fix" three or four times a day
to avoid withdrawal symptoms (Palfai & Jankiewicz, 2001).
Ninety percent of a dose of morphine is excreted in 24 hours
through the kidneys, with most of it metabolized. Traces may be
found in the urine, however, well after 2 days. Another 7 to 10
percent of the dose enters the bile and passes out through the
gastrointestinal tract. (Palfai & Jankiewicz, 2001).
PRIMARY BEHAVIOR CHANGES:
Although heroin's creator, Heinrich Dreser, pronounced heroin as
an effective treatment for a variety of respiratory ailments, such
as bronchitis, asthma and tuberculosis, it's use is illegal. Even
though the medical and psychological fields can not use heroin,
specifically, there are other forms that can be used.
Medicinally, several forms of opioids are used such as opium,
morphine, codeine, and other opium derivatives such as
hydromorphine (Dilaudid), meperidine (Demerol), oxycodone
(Percodan, Percocet), and hydrocodone (Vicodin, Lortab, Lorcet),
and Fentanyl (HYPERLINK ' http://www.acde.org/common/Heroin.htm
').
All of these are used for pain control and have been used for
calming and sedation. Fentanyl is the most powerful synthetic
used for severe pain and as a surgical anesthetic (HYPERLINK '
http://www.acde.org/common/Heroin.htm ').
In the psychological arena, the one most used would be Methadone.
Methadone is most known for its aid in the treatment of heroin
addiction. Methadone, a mu-opioid agonist often used to
substitute for heroin in treatment of heroin addiction is well
absorbed orally and has a much longer duration of action. Thus
methadone maintenance avoids the rapid cycling between
intoxication and withdrawal associated with heroin addiction.
Also, by keeping the addict physically tolerant to opioids,
methadone effectively blocks the euphoric effects of heroin. In
this way, methadone has shown some success as a 'less harmful
substitute'; it is in fact the single most effective treatment
known for opioid addiction, and is recommended for those who have
repeatedly complete detoxification. (HYPERLINK '
http://en.wikipedia.org/wiki/Heroin ').
The theory behind the methadone use is the user will not be
inclined to venture out and seek heroin on the street. Methadone
does not produce the same high as heroin, but it does help the
addict with withdrawals and the cravings that opioids produce.
Methadone paired with several other tools is the most effective.
Patients in methadone maintenance programs also receive
counseling, vocational training, and education to help them reach
the ultimate goal of a drug-free normal life (HYPERLINK '
http://www.well.com/user/woa/fsheroin.htm
').
Refernces
Basic facts about drugs: heroin, (n.d.). Retrieved March 21, 2005
fromhttp://www.acde.org/common/Heroin.htm.
Deadly short cuts, (n.d.). Retrieved March 21, 2005 from
http://heroin.org/heroin.html.
Heroin, (n.d.). Retrieved March 21, 2005 from
http://en.wikipedia.org/wiki/Heroin.
Heroin (and other opiates), (n.d.). Retreived March 21, 2005 from
http://www.drugscope.org.uk/druginfo/drugsearch/ds...
Heroin and other opiates, (n.d.). Retrieved March 21, 2005 from
http:/www.well.com/user/woa/fsheroin.htm.
Palfai, T., Jankiewicz, H. (2001). Drugs and human behavior.
McGraw Hill Primis: New York.
Toxicity, Heroin, (2004). Retrieved March 21, 2005 from
http://emedicine.com/med/topic1003.htm.
Go back to the beginning
Copyright © 2005, Dr. John M. Morgan, All rights reserved -
This page last edited 04-23, 2004
If you have any feedback for the author, E-mail me